Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Rotterdam study assesses risk factors for dementia and AD

May 7, 1997

Warner-Lambert reveals agents with dual dopaminergic/serotonergic activity

May 7, 1997

nAChR ligands prepared by Novo Nordisk

May 7, 1997

Kyowa Hakko claims analgesic agents

May 7, 1997

Analgesics reported by Daiichi and Fuji

May 7, 1997

Preclinical studies with sodium channel blockers in traumatic brain injury

May 6, 1997

Transdermal N-0923 effective in Parkinson's disease

May 6, 1997

COX-2 inhibitor shows potential for preventing neuronal death

May 6, 1997

FDA clears generic version of SKB's Compazine

May 6, 1997

Clinical efficacy of Myotrophin in ALS and postpolio syndrome

May 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...